![Stephen Prior](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Prior
No más puestos en curso
Fortuna: 327 927 $ al 31/08/2026
Perfil
Stephen D.
Prior is the founder of DynPort Vaccine Co. LLC.
Former jobs include Executive Director at National Defense University from 2006 to 2024, Chief Strategy Officer at AN2 Therapeutics, Inc., and Chief Scientific Officer at Exponential Biotherapies, Inc. Education includes a doctorate from the University of Warwick and an undergraduate degree from the University of Kent.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AN2 THERAPEUTICS, INC. 0,16 % | 06/01/2026 | 59.086 ( 0,16 % ) | 327 927 $ | 31/08/2026 |
Antiguos cargos conocidos de Stephen Prior.
| Empresas | Cargo | Fin |
|---|---|---|
National Defense University
 National Defense University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2024 |
DynPort Vaccine Co. LLC
 DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical, vaccine and medical product development & licensure services | Fundador | - |
| AN2 THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Exponential Biotherapies, Inc.
 Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Director Técnico/Científico/I+D | - |
Formación de Stephen Prior.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
10
Relaciones de 1er grado
6
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Exponential Biotherapies, Inc.
Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
DynPort Vaccine Co. LLC
DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical, vaccine and medical product development & licensure services | Commercial Services |
National Defense University
National Defense University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kent
 University of Kent Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AN2 Therapeutics, Inc.
 AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
- Bolsa de valores
- Insiders
- Stephen Prior
